鲍什健康第二季度业绩远超预期，股价上涨

英为财情

2025/07/31

Investing.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期，推动股价上涨2.8%，投资者对公司强劲表现和乐观前景反应积极。这家制药公司第二季度调整后每股收益为0.40美元，显著超过分析师共识的0.04美元。营收达到25.3亿美元，高于预期的24.8亿美元，较去年同期的24亿美元...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2555078099"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555078099\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555078099?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-31 07:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555078099","market":"sh","top_or_hot":-1,"title":"鲍什健康第二季度业绩远超预期，股价上涨","media":"英为财情","content":"<div>\n<p>Investing.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期，推动股价上涨2.8%，投资者对公司强劲表现和乐观前景反应积极。\n这家制药公司第二季度调整后每股收益为0.40美元，显著超过分析师共识的0.04美元。营收达到25.3亿美元，高于预期的24.8亿美元，较去年同期的24亿美元...</p>\n\n<a href=\"https://cn.investing.com/news/earnings/article-93CH-2911523\">网页链接</a>\n\n</div>\n","source":"investing_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>鲍什健康第二季度业绩远超预期，股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n鲍什健康第二季度业绩远超预期，股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-31 07:36 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cn.investing.com/news/earnings/article-93CH-2911523><strong>英为财情</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期，推动股价上涨2.8%，投资者对公司强劲表现和乐观前景反应积极。\n这家制药公司第二季度调整后每股收益为0.40美元，显著超过分析师共识的0.04美元。营收达到25.3亿美元，高于预期的24.8亿美元，较去年同期的24亿美元...</p>\n\n<a href=\"https://cn.investing.com/news/earnings/article-93CH-2911523\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHC","symbol_name":"Bausch Health Companies Inc","start_time":0,"source_url":"https://cn.investing.com/news/earnings/article-93CH-2911523","article_id":"2555078099","we_media_id":null,"thumbnails":[],"rights":{"source":"investing_news","url":"https://cn.investing.com/news/earnings/article-93CH-2911523","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555078099","pubTimestamp":1753918560,"columns":[],"sourceInfo":{"source_id":"investing_news","name":"英为财情新闻"},"weMediaInfo":null,"summary":"Investing.com -- 鲍什健康公司公布的第二季度财报大幅超出分析师预期，推动股价上涨2.8%，投资者对公司强劲表现和乐观前景反应积极。这家制药公司第二季度调整后每股收益为0.40美元，显著超过分析师共识的0.04美元。鲍什健康首席执行官Thomas J. Appio表示：\"在第二季度，不包括Bausch + Lomb，鲍什健康实现了连续第九个季度的营收和调整后EBITDA同比增长。鲍什健康提高了2025财年全年指引，现预计营收在100亿美元至102.5亿美元之间，相比分析师共识的100.37亿美元。","collect":0,"end_time":0,"defaultTopTitle":"investing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BHC":"Bausch Health Companies Inc","BK4007":"制药"},"translate_title":"Bausch Health Stock Rises as Q2 Results Well Beat Expectations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHC":1},"content_text":"Investing.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期，推动股价上涨2.8%，投资者对公司强劲表现和乐观前景反应积极。\n这家制药公司第二季度调整后每股收益为0.40美元，显著超过分析师共识的0.04美元。营收达到25.3亿美元，高于预期的24.8亿美元，较去年同期的24亿美元增长5%。\n鲍什健康首席执行官Thomas J. Appio表示：\"在第二季度，不包括Bausch + Lomb，鲍什健康实现了连续第九个季度的营收和调整后EBITDA同比增长。这种持续的表现凸显了我们的卓越运营能力和我们在各治疗领域和地区的多元化产品组合的实力。\"\n公司的Salix部门表现尤为突出，同比增长12%至6.27亿美元，主要由其Xifaxan产品推动，该产品收入增长10%。Solta Medical部门也取得了令人印象深刻的业绩，增长25%至1.28亿美元。\n鲍什健康提高了2025财年全年指引，现预计营收在100亿美元至102.5亿美元之间，相比分析师共识的100.37亿美元。公司还将调整后EBITDA预测提高至34.85亿美元至36.35亿美元之间，较上一年增长3%至7%。\n本季度公司经营活动产生的现金为2.89亿美元，较2024年第二季度产生的3.8亿美元下降24%。\n鲍什健康继续专注于加强其资产负债表并推进研发管线，多个产品处于后期开发阶段，包括用于肝性脑病的RED-C，其三期临床结果预计将于2026年初公布。\n\n本文由人工智能协助翻译。更多信息，请参见我们的使用条款。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}